A fundamental question for high-temperature superconductors is the nature of the pseudogap phase, which lies between the Mott insulator at zero doping and the Fermi liquid at high doping p (refs 1,2). Here we report on the behaviour of charge carriers near the zero-temperature onset of this phase, namely at the critical doping p *
The three central phenomena of cuprate superconductors are linked by a common doping p*, where the enigmatic pseudogap phase ends, around which the superconducting phase forms a dome, and at which the resistivity exhibits an anomalous linear dependence on temperature as T → 0 (ref. 1). However, the
The Nernst effect in metals is highly sensitive to two kinds of phase transition: superconductivity and density-wave order. The large, positive Nernst signal observed in hole-doped high-T(c) superconductors above their transition temperature (T(c)) has so far been attributed to fluctuating superconductivity. Here we report that in some of these materials the large Nernst signal is in fact the result of stripe order, a form of spin/charge modulation that causes a reconstruction of the Fermi surface. In La(2-x)Sr(x)CuO(4) (LSCO) doped with Nd or Eu, the onset of stripe order causes the Nernst signal to change from being small and negative to being large and positive, as revealed either by lowering the hole concentration across the quantum critical point in Nd-doped LSCO (refs 6-8) or by lowering the temperature across the ordering temperature in Eu-doped LSCO (refs 9, 10). In the second case, two separate peaks are resolved, respectively associated with the onset of stripe order at high temperature and superconductivity near T(c).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.